Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats

A Morelli, S Filippi, P Sandner, B Fibbi… - The journal of sexual …, 2009 - academic.oup.com
Introduction Phosphodiesterase type 5 inhibitors (PDE5i), the most widely used drugs for
erectile dysfunction, could also improve lower urinary tract symptoms, essentially due to …
被引用次数：108 相关文章

Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats

A Morelli, S Filippi, P Sandner, B Fibbi… - JOURNAL OF SEXUAL …, 2009 - flore.unifi.it
Phosphodiesterase type 5 inhibitors (PDE5i), the most widely used drugs for erectile
dysfunction, could also improve lower urinary tract symptoms, essentially due to overactive …

[引用][C] Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats

A MORELLI - J. Sex. Med., 2009 - cir.nii.ac.jp
Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho
kinase signaling pathway in spontaneously hypertensive rats | CiNii Research CiNii 国立 …

Vardenafil Modulates Bladder Contractility Through cGMP‐mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats

A Morelli, S Filippi, P Sandner, B Fibbi… - The Journal of …, 2009 - Wiley Online Library
Introduction. Phosphodiesterase type 5 inhibitors (PDE5i), the most widely used drugs for
erectile dysfunction, could also improve lower urinary tract symptoms, essentially due to …

Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats

A Morelli, S Filippi, P Sandner, B Fibbi… - The Journal of Sexual …, 2009 - Elsevier
Introduction Phosphodiesterase type 5 inhibitors (PDE5i), the most widely used drugs for
erectile dysfunction, could also improve lower urinary tract symptoms, essentially due to …

Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats

A Morelli, S Filippi, P Sandner… - The journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Introduction Phosphodiesterase type 5 inhibitors (PDE5i), the most widely used drugs for
erectile dysfunction, could also improve lower urinary tract symptoms, essentially due to …

Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.

A Morelli, S Filippi, P Sandner, B Fibbi… - The Journal of Sexual …, 2009 - europepmc.org
Aim The aim of this paper was to investigate whether vardenafil-induced cGMP
accumulation reduces RhoA/ROCK signaling in bladder. Methods Spontaneously …

Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signalling pathway in spontaneously hypertensive rats.

A Morelli, S Filippi, P Sandner, B Fibbi… - JOURNAL OF SEXUAL …, 2009 - flore.unifi.it
Phosphodiesterase type 5 inhibitors (PDE5i), the most widely used drugs for erectile
dysfunction, could also improve lower urinary tract symptoms, essentially due to overactive …

[引用][C] Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats

A MORELLI - J. Sex. Med., 2009 - cir.nii.ac.jp
Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho
kinase signaling pathway in spontaneously hypertensive rats | CiNii Research CiNii 国立 …